EGFR-NSCLC Market: Epidemiology, Treatment Landscape, and Pipeline Outlook to 2036 EGFR-NSCLC Market: Epidemiology, Treatment Landscape, and Pipeline Outlook to 2036
Epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) is one of the clearest examples of biomarker-driven oncology. A single genetic driver defines the patient population, targeted drugs have transformed outcomes, and the commercial stakes are large. This article draws on...
0 Compartilhamentos
29 Visualizações